GlassScriptPhysician profile
Ronald Huang
NPI 1801153911
$6,516.41
in general payments reported to CMS, 2019-2025
16 companies · $637 in 2025
The $637 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,076 · 2020: $145 · 2021: $351 · 2022: $87.10 · 2023: $3,852 · 2024: $369 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,376 · Food and Beverage: $1,481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,375.84 |
| Food and Beverage | $1,481.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uoc USA INC | $3,873.01 | 2020-2025 | Ustar II, Uts, Conformity, U-Mii, U2 Revision Stem, Psa, Ustar, U2 Knee |
| Medical Device Business Services, INC. | $779.67 | 2019 | |
| Stryker Corporation | $752.84 | 2019-2025 | Mako, Triathlon, Gmrs |
| Zimmer Biomet Holdings, INC. | $222.34 | 2024-2025 | Comprehensive Shoulder System, Persona |
| Conformis, INC. | $142.29 | 2021 | |
| Globus Medical, INC. | $126.83 | 2025 | Senza |
| Vertex Pharmaceuticals Incorporated | $123.11 | 2025 | |
| Endo Pharmaceuticals INC. | $114.72 | 2021 | |
| Depuy Synthes Sales INC. | $105.97 | 2019 | |
| Convatec INC. | $92.23 | 2023 | |
| Aesculap Implant Systems, LLC | $60.95 | 2019 | |
| Bioventus LLC | $40.78 | 2025 | Xcell |
| Dompe US, INC. | $24.08 | 2022 | |
| Abbvie INC. | $20.56 | 2023 | |
| Linkbio Corp | $20.32 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gotham Surgical Solutions & Devices, INC. | $16.71 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.